麻豆视频

Global Flavonoid Market Trends and Insights

Growing Demand for Anti-Inflammatory Joint Health Supplements

The increasing elderly population and growing focus on preventive healthcare drive the demand for flavonoids in joint health applications, as quercetin and other flavonoids show proven anti-inflammatory properties. In February 2025, the Food and Drug Administration's final rule updated the definition of "healthy" as an implied nutrient content claim to align with current nutrition science and Federal dietary guidance, particularly the Dietary Guidelines for Americans.^{[2]Source: Federal Register, "Food Labeling: Nutrient Content Claims; Definition of Term Healthy", federalregister.gov} This revision establishes requirements for using "healthy" in human food product labeling, helping consumers identify nutritious foods that align with dietary recommendations and encouraging manufacturers to fortify snacks and beverages with flavonoids that meet nutrient-density criteria. The nutraceutical market continues to consume higher volumes, maintaining premium raw-material prices despite increased competition. The combination of flavonoids with conventional active ingredients reduces pill consumption and improves consumer adherence, establishing flavonoids as complementary ingredients rather than replacements. The industry's focus on joint-health claims is evidenced by investments in pilot-scale encapsulation facilities.

Antiviral and Antimicrobial Applications in Natural Remedies

Growing health awareness drives the incorporation of flavonoids in immune support products, as compounds such as baicalin and baicalein demonstrate proven antiviral and antimicrobial effects in clinical studies. The therapeutic use of flavonoids increases as regulatory bodies in Asian countries, especially China and India, recognize traditional herbal medicines containing these compounds, establishing comprehensive market entry pathways and standardized approval processes. Asian nutraceutical regulations emphasize stringent safety and efficacy standards, favoring scientifically validated flavonoid compounds through extensive research and documentation requirements. The ability of flavonoids to serve both preventive and therapeutic functions strengthens their position in the immune health market, particularly as consumers seek natural alternatives supported by robust scientific evidence and clinical validation. This dual functionality, combined with increasing regulatory acceptance and consumer demand, creates significant opportunities for manufacturers developing flavonoid-based immune support products.

Use as Natural Colorants in Food and Beverage

The flavonoid market is undergoing significant changes due to increasing consumer demand for natural and clean-label products. Food manufacturers are responding by reformulating their products with natural ingredients, which has increased flavonoid usage across multiple applications. The industry has increased investments in research and development to improve the stability and functionality of flavonoid-based ingredients, particularly for food and beverage products. The FDA's 2025 approval of three natural colors created new market opportunities and supported the food industry's transition from artificial to natural colorants.^{[3]Source: FDA, "FDA Approves Three Food Colors from Natural Sources", fda.gov} This regulatory development coincided with improvements in colorant stability technology. The European Union's ongoing comprehensive review of food colors, including Vegetable carbon (E 153) and Iron oxides (E 172), benefits natural alternatives that meet safety standards.^{[4]Source: European Food Safety Authority, "Food Colors" efsa.europa.eu} Food manufacturers are increasingly using anthocyanin-rich sources, particularly berries, to provide both visual appeal and health benefits. The combination of regulatory support, technological advancements, and consumer preferences is driving the adoption of flavonoid-based colorants in beverages, confectionery, and processed foods.

Increasing Demand for Anti-Bacterial Properties in Skincare Products

The cosmetics industry is incorporating functional ingredients, particularly flavonoids, into skincare formulations based on their proven anti-aging and photoprotective properties. Research shows that anthocyanins enhance collagen production and protect skin cells from UV-induced oxidative damage, making them essential components in anti-aging products. The combination of apigenin and phloretin serves as an effective alternative to hydroquinone for treating melasma, resulting in new brightening serum formulations. European regulations list 309 permitted colorants, including botanical sources, providing manufacturers with clear compliance guidelines for product development. The nutricosmetics market expansion indicates increased consumer awareness of the relationship between internal antioxidant consumption and skin health, leading to integrated supplement and topical product offerings with standardized flavonoid extracts. This development has resulted in comprehensive skincare solutions addressing both internal and external skin health factors. Product communication now emphasizes scientific evidence over traditional natural ingredient messaging, highlighting the documented effectiveness of flavonoid-based formulations for specific skin concerns.

Limited Shelf Life

The degradation of flavonoids during storage and processing creates significant technical and economic challenges for market growth, particularly in applications requiring long shelf life. The stability of anthocyanins heavily depends on environmental factors such as pH levels, temperature conditions, and light exposure, which directly affect their biological effectiveness and commercial viability in various applications. Advanced encapsulation technologies and co-pigmentation methods, while effective in improving stability, significantly increase production costs and add complexity to manufacturing processes. Anthocyanin-based intelligent packaging systems function as comprehensive pH indicators, providing sophisticated color-change capabilities for continuous product monitoring throughout the supply chain. Ongoing research on flavonoid-based nanogels demonstrates considerable potential for improved stability and bioavailability, though scaling these solutions for commercial production remains technically challenging. These stability concerns primarily impact the food and beverage industry, where natural colorants must consistently maintain their visual and functional properties throughout extended distribution and storage periods, often lasting several months.

Dependency on Seasonal and Regional Crop Supply

Climate-related supply disruptions significantly affect the pricing and availability of flavonoids, particularly those derived from citrus fruits and berries. The impact extends across the entire supply chain, from agricultural production to final product manufacturing. According to the European Commission, the European Union's citrus production (excluding grapefruit) decreased from 10.3 million tons in 2022 to 7.4 million tons in 2023, primarily due to drought, restricted irrigation, and high temperatures.^{[5]Source: European Commission, "Citrus fruit statistics", agriculture.ec.europa.eu} Environmental stresses, such as temperature fluctuations and increased pest pressures in kiwifruit production, demonstrate the vulnerability of flavonoid source crops to changing climate patterns. The geographic concentration of flavonoid sources creates substantial systemic risks for global pricing and availability, especially as demand growth exceeds supply expansion in key agricultural regions. In response to these challenges, companies implement comprehensive supply chain resilience strategies, including geographic diversification, alternative source development, and improved storage solutions to maintain market stability and ensure consistent supply to meet growing market demands.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Type: Anthocyanins Retain Lead While Flavonols Accelerate

Anthocyanins dominated the Flavonoids market with a 29.12% share in 2025, driven by their applications as natural colorants and antioxidants. Recent regulatory approvals for butterfly pea and increased demand for natural blue colors in beverage reformulations support this segment's growth. Flavonols, particularly quercetin, demonstrate a 6.12% CAGR, supported by expanding applications in cardiovascular and metabolic health. Recent developments in water-soluble 3-hydroxyflavonol technology enhance bioavailability, increasing clinical applications. Flavan-3-ols maintain stable growth due to FDA cardiovascular qualified health claims for cocoa powders, while flavones and isoflavones serve specific hormonal health applications. During the forecast period, increased therapeutic validation and pharmaceutical trials position flavonols to reduce the market share gap.

The market for flavonols continues to expand through ongoing research and development, while anthocyanins maintain their market position through color innovation. Manufacturers gain competitive advantages through improved stability technologies, securing premium contracts with major beverage and beauty companies. Growing clinical evidence for flavonol efficacy is expected to increase healthcare provider acceptance and expand over-the-counter availability, facilitating broader market penetration in mainstream health channels.

By Source: Berries Dominate but Herbs and Spices Gain Ground

Berries contributed 27.10% of the Flavonoids market size in 2025, supported by established supply chains and widespread use of blueberry and blackcurrant extracts. However, climate-related yield variations create price volatility that affects processor margins. The herbs and spices segment grows at 6.33% CAGR, supported by the continuous cultivation of Scutellaria and rosemary, which provide concentrated active compounds at lower doses. Citrus maintains its market position through efficient hesperidin production, though disease and drought concerns lead to geographic diversification of sources. Soybean isoflavones serve the menopause support segment, while tea and cocoa maintain stable demand due to traditional consumption patterns.

Manufacturers distribute sourcing across hemispheres to minimize weather-related disruptions and maintain market stability. Fermentation facilities test baicalin production using stainless-steel bioreactors, reducing dependence on crop cycles and minimizing pesticide exposure. This approach ensures consistent quality and meets environmental, social, and governance (ESG) requirements, positioning herb-derived and fermentation-derived flavonoids as risk management tools. As regulatory requirements for product disclosure increase, supply chain traceability becomes crucial in supplier selection, benefiting sources with comprehensive audit systems.

By Form: Powder Remains Pre-Eminent While Novel Systems Emerge

Powder formats maintained a 63.25% market share in 2025, primarily due to their shelf stability, ease of blending, and compatibility with existing dry-mix infrastructure. Liquid variants are essential for beverage and cosmetic emulsions requiring rapid dispersion but face challenges with oxidation and microbial contamination, which reduce shelf life. The "others" category, experiencing a 6.45% CAGR, includes nanogels, beadlets, and co-extruded cylinders that improve bioavailability and enable pH-triggered release. Aqueous two-phase extraction technology produces high-purity concentrates suitable for injectable pharmaceuticals.

End-users prioritize cost per effective dose over raw material costs, making high-loading beadlets economically viable despite higher unit prices. Advanced moisture-barrier film packaging helps maintain product potency and reduces waste. The industry's shift toward clean labels has increased the adoption of solvent-free granulation methods. While powder formats continue to dominate the Flavonoids market, the industry is gradually moving toward specialized delivery systems that influence product development strategies.

By Application: Nutraceuticals Drive Multi-Sector Expansion

Nutraceuticals hold 35.20% of the Flavonoids market share in 2025 and maintain a 5.55% CAGR, driven by physician-supported claims for joint health, liver function, and immune system support. Food and beverage manufacturers are reformulating products with plant-based colors, supported by the 2025 GRAS regulatory reforms emphasizing transparency. The pharmaceutical industry is conducting Phase 1 and Phase 2 clinical trials of chrysin and quercetin for metabolic disorders, suggesting potential prescription drug development. The cosmetics industry incorporates anthocyanin complexes for UV protection, with increasing adoption of combined topical and oral treatment approaches.

The animal feed industry is evaluating Scutellaria flavonoids as natural growth promotants, in response to regulations limiting antimicrobial use in livestock. Multi-purpose applications, such as packaging films that function as pH indicators, demonstrate how single extracts can benefit multiple industrial segments. This diversification protects the Flavonoids market from demand fluctuations in individual sectors while encouraging innovation that extends intellectual property across multiple categories.

Geography Analysis

North America accounted for 32.10% of 2025 revenue, supported by FDA health-claim clarity and established supplement distribution channels. The region faces challenges from citrus greening disease and extreme weather conditions, driving companies to source ingredients from Latin America or through fermentation processes. IFF's USD 70 million investment in February 2025 to expand its Cedar Rapids, Iowa, facility by 47,000 square feet demonstrates a commitment to domestic production. The expansion, scheduled for completion in 2026, will increase Taura by IFF fruit ingredients production to serve the healthy snacks market. While retailers value U.S.-grown ingredients, buyers accept imported alternatives during domestic supply shortages and price increases.

Asia-Pacific shows the highest growth rate at 6.14% CAGR, driven by expanding middle-class consumption, acceptance of traditional medicine, and emerging manufacturing centers. China's incorporation of validated flavonoids in its functional-food catalogue and India's Ayurvedic standards create efficient approval processes, reducing time-to-market. The expansion of e-commerce beyond urban areas increases market penetration and sales volume.

Europe maintains consistent growth, supported by strict additive regulations and environmentally conscious consumers. EFSA's reassessment of existing colorants creates opportunities for flavonoid alternatives that avoid extensive toxicological reviews. Ongoing drought conditions reduce EU citrus production, limiting regional hesperidin availability and increasing interest in Blackcurrant and Elderberry alternatives. The cosmetics industry in France and Italy benefits from comprehensive regulations covering 309 approved colorants, facilitating faster development of skincare products containing flavonoids.

Regulatory Landscape

In the United States, flavonoid-based ingredients used as colors, extracts, or functional components generally sit under FDA food additive and GRAS pathways, with labeling and implied nutrient content claims shaping go-to-market approaches for nutraceuticals and fortified foods. A near-term compliance inflection point is the FDA agenda item (RIN 0910-AJ02), which targets amendments to 21 CFR parts 170 and 570 to introduce mandatory GRAS notice submissions for certain human and animal food uses. The agenda lists a proposed rule timing aligned to December 2026, which raises the bar for documentation and early regulatory engagement for novel or high-use botanical flavonoid preparations.

In Europe, flavonoid concentrates and certain botanical extracts are governed by the Novel Food Regulation (EU) 2015/2283, with EFSA risk assessment underpinning authorization and, in some cases, time-limited data protection. Recent EU actions illustrate this pathway: in February 2025, the European Commission authorized glucosyl hesperidin for placing on the market as a novel food for a five-year period (for Nagase Viita Co., Ltd.). In parallel, the Novel Food Catalogue update (January 2026) reinforced that while some plant parts used in supplements may be non-novel, purified bioflavonoids such as quercetin and rutin can still trigger pre-market authorization when supplied at specific high-concentration criteria. This influences ingredient standardization decisions for supplement and functional food launches.

Value Chain Analysis

The flavonoid value chain starts with agricultural feedstocks (citrus fruits, berries, tea, cocoa, and herbs and spices) and extends through primary processing, extraction and purification, formulation (powders, liquids, and delivery systems such as beadlets or liposomal formats), and distribution to food and beverage, nutraceutical, pharmaceutical, and cosmetic manufacturers. Crop seasonality and climate variability in key sources, notably citrus and berries, remain upstream risks that affect availability, quality consistency, and pricing. As a result, buyers tend to tighten specifications, increase traceability expectations, and diversify origins.

Value addition is concentrated in extraction, purification, and stabilization. Suppliers use technologies such as supercritical fluid extraction, ultrasound-assisted extraction, and microwave-assisted extraction to improve yield and reduce solvent and energy intensity. Downstream, regulatory compliance, including FDA GRAS/food additive status in the United States and EFSA-led evaluations, E-number additive rules, and EU Novel Food procedures, increases documentation and quality system requirements. This tends to favor integrated operators and audited suppliers. To reduce dependence on harvest cycles and meet clean-label and sustainability requirements, the chain is also incorporating precision fermentation and advanced encapsulation platforms to convert commodity feedstocks into standardized, application-ready flavonoid ingredients.

Market Opportunities and Future Outlook

Sugar reduction and sensory performance in beverages and plant-forward formulations are broadening how manufacturers use flavonoids. Beyond antioxidant positioning, the ingredients are being positioned for taste modulation, bitterness management, and sweetening systems. A specific example is HealthTech Bioactives' July 2026 launch of Citrose, a patented citrus-based high-intensity sweetener sourced from immature bitter orange (Citrus aurantium) and aimed at reduced-sugar beverages and dairy alternatives. This introduces whitespace for citrus-derived bioflavonoid solutions that target both functionality and formulation performance.

Delivery technologies that address solubility and bioavailability constraints are creating opportunities across nutraceuticals, functional foods, and beauty-from-within positioning, where hydrophobic flavonoids can face absorption limits in conventional formats. Ceres Biotech introduced a liposomal apigenin powder (July 2026) in 50% and 70% concentrations, reinforcing continued productization of advanced delivery systems as suppliers compete on efficacy-per-dose, dispersion behavior, and stability in real-world matrices. On the regulatory front, EU Novel Food authorizations and EFSA safety work, together with ongoing EU additive re-evaluation activity with status updates published through February 2026, keep high-concentration extracts and new processing routes focused on data quality, standardized specifications, and compliant claims substantiation. This favors manufacturers able to pair clinical and safety dossiers with scalable, traceable supply.